Bausch Health Companies | VRX - Cost Of Sales

Stock Price
8.03
Daily Change
0.19 2.42%
Monthly
-26.67%
Yearly
-13.00%
Q1 Forecast
7.62

Bausch Health Companies reported $750M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Amgen USD 1.79B 128M Dec/2025
ANI Pharmaceuticals USD 116.02M 18.12M Sep/2025
Aurora Cannabis CAD 58.08M 11.99M Sep/2025
Bausch Health Companies USD 750M 14M Sep/2025
Biogen USD 810.1M 205.1M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Canopy Growth CAD 44.78M 9.32M Sep/2025
Corcept Therapeutics USD 4.6M 1.16M Sep/2025
Danaher USD 2.87B 342M Dec/2025
Drreddys Laboratories INR 40.46B 3.64B Dec/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Gilead Sciences USD 1.57B 68M Sep/2025
Novo Nordisk DKK 15.15B 2.3B Dec/2025
Pacira USD 48.6M 6.59M Sep/2025
Perrigo USD 666.2M 27.2M Sep/2025
Prestige Brands USD 131.22M 3.52M Dec/2025
Supernus Pharmaceuticals USD 43.29M 5.64M Sep/2025
Vertex Pharmaceuticals USD 414.8M 7.3M Sep/2025
Zoetis USD 683M 3M Sep/2025